EDGAR Filing Documents for 0001102624-13-001174

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001102624-13-001174

Filing Date

2013-09-30

Accepted

2013-09-27 18:27:33

Documents

Period of Report

2013-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	MEDICURE INC. 20-F	medicure20f.htm	20-F	2381300
2	EXHIBIT 12.1	exh12_1.htm	EX-12.1	12806
3	EXHIBIT 12.2	exh12_2.htm	EX-12.2	12671
4	EXHIBIT 13.1	exh13_1.htm	EX-13.1	10243
5	EXHIBIT 23.1	exh23_1.htm	EX-23.1	8364
6	IMAGE	exh231image.jpg	GRAPHIC	3574
7	IMAGE	ex991image1.jpg	GRAPHIC	3308
	Complete submission text file	0001102624-13-001174.txt		2436133

Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6

Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412

MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 131121027
SIC: 2834 Pharmaceutical Preparations